Radiopharmaceuticals Market to grow at a CAGR of 9.02% with Application, Opportunity and Forecast to 2021
Radiopharmaceuticals Market, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years.
(EMAILWIRE.COM, February 22, 2018 ) Radiopharmaceuticals are pharmaceutical drugs having radioactive properties. The drugs can be used for therapeutic and diagnostic purposes. It is made up of radioisotope that bonds to an organic molecule. The radiopharmaceuticals find large application in the medical field due to their intrinsic properties. The radiopharmaceutical market is expected to benefit from the growing demand from the cancer market. Cancer is one of the major segments having a huge demand for radiopharmaceuticals for both therapeutic and diagnostic segments. Some of the other major segments finding the huge application of radiopharmaceuticals are neurology, cardiology, and thyroid disorder treatment.
Publisher's analysts forecast the global radiopharmaceuticals market to grow at a CAGR of 9.02% during the period 2017-2021.
Request sample copy @ http://www.reportsweb.com/inquiry&RW0001986779/sample
Neurological disorders are related to the brain, spine, and the nerves. Epilepsy, Parkinson's disease, brain tumors, and stroke are some of the most common diseases of the nervous system. One of the less familiar neurological disorders includes frontotemporal dementia. The growing geriatric population has resulted in the increasing number of people suffering from neurological disorders such as Alzheimer's disease. To diagnose brain disorders, many healthcare units employ single photon emission computed tomography (SPECT) and positron emission tomography (PET) imaging instruments. These imaging instruments use radiopharmaceuticals to diagnose the neurological disorders.
Key vendors
-Bayer,
-Cardinal Health,
-GE Healthcare,
-Lantheus Medical Imaging
Other prominent vendors
-ABT Molecular Imaging
-Advanced Accelerator Applications
-Algeta
-Eczacibasi-Monrol Nuclear Products
-FUJIFILM Holdings
-Isologic Innovative Radiopharmaceuticals
-Nordion
-Piramal Imaging
-RadioMedix
Have any query? Enquire about report @ http://www.reportsweb.com/inquiry&RW0001986779/buying
Market driver
-Rising burden of the neurological disorders
Market challenge
-Shortage of radioisotopes
Market trend
-Partnerships for development of radiopharmaceuticals
Fundamentals of Table of Content:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Global construction market
PART 06: Market drivers
PART 07: Market trends
PART 08: Global AEC market
PART 09: Market segmentation by product
PART 10: Geographical segmentation
PART 11: Market challenges
PART 12: Impact of drivers and challenges
PART 13: Five forces model
PART 14: Key vendor analysis
PART 15: Key vendor profiles
Buy now @ http://www.reportsweb.com/buy&RW0001986779/buy/3500
Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Publisher's analysts forecast the global radiopharmaceuticals market to grow at a CAGR of 9.02% during the period 2017-2021.
Request sample copy @ http://www.reportsweb.com/inquiry&RW0001986779/sample
Neurological disorders are related to the brain, spine, and the nerves. Epilepsy, Parkinson's disease, brain tumors, and stroke are some of the most common diseases of the nervous system. One of the less familiar neurological disorders includes frontotemporal dementia. The growing geriatric population has resulted in the increasing number of people suffering from neurological disorders such as Alzheimer's disease. To diagnose brain disorders, many healthcare units employ single photon emission computed tomography (SPECT) and positron emission tomography (PET) imaging instruments. These imaging instruments use radiopharmaceuticals to diagnose the neurological disorders.
Key vendors
-Bayer,
-Cardinal Health,
-GE Healthcare,
-Lantheus Medical Imaging
Other prominent vendors
-ABT Molecular Imaging
-Advanced Accelerator Applications
-Algeta
-Eczacibasi-Monrol Nuclear Products
-FUJIFILM Holdings
-Isologic Innovative Radiopharmaceuticals
-Nordion
-Piramal Imaging
-RadioMedix
Have any query? Enquire about report @ http://www.reportsweb.com/inquiry&RW0001986779/buying
Market driver
-Rising burden of the neurological disorders
Market challenge
-Shortage of radioisotopes
Market trend
-Partnerships for development of radiopharmaceuticals
Fundamentals of Table of Content:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Global construction market
PART 06: Market drivers
PART 07: Market trends
PART 08: Global AEC market
PART 09: Market segmentation by product
PART 10: Geographical segmentation
PART 11: Market challenges
PART 12: Impact of drivers and challenges
PART 13: Five forces model
PART 14: Key vendor analysis
PART 15: Key vendor profiles
Buy now @ http://www.reportsweb.com/buy&RW0001986779/buy/3500
Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results